Genetic testing is transforming depression treatment by tailoring antidepressants to your DNA for better results and fewer ...

- Elumina is a Phase 2, multicenter, double-blind, randomized, placebo-controlled, clinical trial to assess the efficacy, ...

The trial’s primary objective is to assess PALI-2108’s tolerability, pharmacokinetics and safety in healthy volunteers.

The eight-week, open-label, extension stage of the Phase 2b clinical trial continues to enroll patients to evaluate the safety and efficacy of a second high dose of BPL-003 administered after the ...

The results of COMP004 build upon previous findings from the Phase 2b trial COMP001, which showed that a single 25mg dose of COMP360 psilocybin was associated with a rapid and highly statistically ...

In a nutshell Nearly half (48%) of depression patients don’t respond to standard treatments, revealing a significant gap in ...

Michael Jordan's son, Marcus Jordan, has made a sad admission following his arrest earlier this year. Marcus Jordan, a former ...

Neumora halted one trial of its depression drug navacaprant and paused a pair of late-stage studies as it tries to learn from a recent phase 3 failure. The KOASTAL-1 study, which read out in ...

Sensible media outlets carried only a blurred version, but within the confines of a crowded courtroom in Buenos Aires on Tuesday, at the outset of a trial that has been more than four years in ...

A Derbyshire man accused of murdering his girlfriend during a domestic row told police he was “full of regret” and felt ...

NEW YORK and BERLIN, March 05, 2025 (GLOBE NEWSWIRE) -- atai Life Sciences (NASDAQ: ATAI) (“atai” or “Company”), a clinical-stage biopharmaceutical company aiming to transform the ...